Injection site reactions are the most commonly reported dermatological effects with subcutaneous semaglutide (Ozempic and Wegovy) and typically present as redness, itching, bruising, or mild swelling at the site of administration
Cagrilintide (10mg) is typically listed in research catalogs as a peptide for laboratory use, particularly in metabolic and appetite regulation research models
This results in somewhat empirical material design, making precise regulation difficult to meet the different requirements for dominant storage mechanisms in specific application scenarios
65 ForstTPftznerA
This method is a prevalent technique employed in pharmacovigilance research to detect safety signals [Reference Chen, Ding, Fu and Xiao16Reference He, Lam, Zhao, Yang, Li and Mo18]